Rate for 100,000 people with low exposure risk
(based on coronavirus incidence of 2 per 10,000,
as was roughly the UK in March)
Potential benefits
ICU admissions prevented by having the AZ vaccine
0
3
6
9
12
15
Age 20-29
0.8
30-39
2.7
40-49
5.7
50-59
10.5
60-69
14.1
Potential harms
Serious harms due to having the AZ vaccine
0
3
6
9
12
15
Age 20-29
1.1
30-39
0.8
40-49
0.5
50-59
0.4
60-69
0.2
Rate for 100,000 people with low exposure risk (based on coronavirus incidence of 2 per 10,000,
as was roughly the UK in March)
Potential benefits
ICU admissions prevented by having the AZ vaccine
Potential harms
Serious harms due to having the AZ vaccine
Age group
15
12
9
6
3
0
3
6
9
12
15
0
1.1
20-29
0.8
2.7
30-39
0.8
0.5
5.7
40-49
10.5
0.4
50-59
0.2
14.1
60-69